DK494289A - Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge - Google Patents

Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge Download PDF

Info

Publication number
DK494289A
DK494289A DK494289A DK494289A DK494289A DK 494289 A DK494289 A DK 494289A DK 494289 A DK494289 A DK 494289A DK 494289 A DK494289 A DK 494289A DK 494289 A DK494289 A DK 494289A
Authority
DK
Denmark
Prior art keywords
prostaglandianalogue
analogy
preparation
therapeutically applied
therapeutically
Prior art date
Application number
DK494289A
Other languages
English (en)
Other versions
DK494289D0 (da
Inventor
Masaki Hayashi
Seiji Kori
Hajimu Miyake
Takanori Okada
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB34688/75A external-priority patent/GB1521747A/en
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK494289A publication Critical patent/DK494289A/da
Publication of DK494289D0 publication Critical patent/DK494289D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK494289A 1975-08-20 1989-10-06 Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge DK494289D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB34688/75A GB1521747A (en) 1975-08-20 1975-08-20 Prostaglandin analogues
GB4346475 1975-10-22

Publications (2)

Publication Number Publication Date
DK494289A true DK494289A (da) 1989-10-06
DK494289D0 DK494289D0 (da) 1989-10-06

Family

ID=26262398

Family Applications (2)

Application Number Title Priority Date Filing Date
DK370576A DK370576A (da) 1975-08-20 1976-08-17 Fremgangsmade til fremstilling af prostaglandinanaloge
DK494289A DK494289D0 (da) 1975-08-20 1989-10-06 Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK370576A DK370576A (da) 1975-08-20 1976-08-17 Fremgangsmade til fremstilling af prostaglandinanaloge

Country Status (12)

Country Link
US (1) US4065632A (da)
JP (1) JPS5825669B2 (da)
AU (1) AU501896B2 (da)
CA (1) CA1091663A (da)
CH (1) CH613950A5 (da)
DE (1) DE2637393C2 (da)
DK (2) DK370576A (da)
FR (1) FR2321277A1 (da)
HK (1) HK7081A (da)
IE (1) IE44161B1 (da)
LU (1) LU75622A1 (da)
NL (1) NL7609134A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092349A (en) * 1976-11-10 1978-05-30 Pfizer Inc. 11-Desoxy-15-thiaprostaglandins
US4148804A (en) * 1978-01-11 1979-04-10 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl) 11-desoxy-15-thiaprostaglandins

Also Published As

Publication number Publication date
IE44161B1 (en) 1981-08-26
FR2321277A1 (fr) 1977-03-18
LU75622A1 (da) 1977-04-21
DK494289D0 (da) 1989-10-06
DE2637393C2 (de) 1984-03-29
NL7609134A (nl) 1977-02-22
US4065632A (en) 1977-12-27
HK7081A (en) 1981-03-13
CH613950A5 (da) 1979-10-31
IE44161L (en) 1977-02-20
AU1691376A (en) 1978-02-23
DE2637393A1 (de) 1977-02-24
AU501896B2 (en) 1979-07-05
FR2321277B1 (da) 1981-03-20
JPS5825669B2 (ja) 1983-05-28
DK370576A (da) 1977-02-21
CA1091663A (en) 1980-12-16
JPS5225745A (en) 1977-02-25

Similar Documents

Publication Publication Date Title
DK151013C (da) Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK113476A (da) Fremgangsmade til fremstilling af amoxicillintrihydrat
DK146542C (da) Analogifremgangsmaade til fremstilling af daunosaminylanthracyclioner
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK150478C (da) Analogifremgangsmaade til fremstilling af n-aryl-n-(4-piperidyl)-arylacetamidderivater
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK122876A (da) Fremgangsmade til fremstilling af foderstoffer
DK494289A (da) Analogifremgangsmaade til fremstilling af terapeutisk anvendelige prostaglandianaloge
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK142845C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK142280C (da) Fremgangsmaade til fremstilling af 4-aminopyridiner
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK246976A (da) Fremgangsmade til fremstilling af isoquinoliner
DK55476A (da) Fremgangsmade til fremstilling af dinitronaphthalener

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment